Dacthal

CASRN 1861-32-1

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (17 pp, 132 K) last updated: 08/01/1994

RfD (mg/kg-day) System Basis PoD Composite UF Confidence
1 x 10-2 Respiratory Effects on the lungs, liver, kidney, thyroid and thyroid hormones in males and females and eyes of females NOAEL : 1
mg/kg-day
100 High
1 x 10-2 Urinary Effects on the lungs, liver, kidney, thyroid and thyroid hormones in males and females and eyes of females NOAEL : 1
mg/kg-day
100 High
1 x 10-2 Endocrine Effects on the lungs, liver, kidney, thyroid and thyroid hormones in males and females and eyes of females NOAEL : 1
mg/kg-day
100 High
1 x 10-2 Hepatic Effects on the lungs, liver, kidney, thyroid and thyroid hormones in males and females and eyes of females NOAEL : 1
mg/kg-day
100 High
1 x 10-2 Ocular Effects on the lungs, liver, kidney, thyroid and thyroid hormones in males and females and eyes of females NOAEL : 1
mg/kg-day
100 High

Reference Concentration for Inhalation Exposure (RfC) (PDF) (17 pp, 132 K)
Not assessed under the IRIS Program.

Cancer Assessment


Weight of Evidence for Cancer (PDF) (17 pp, 132 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (17 pp, 132 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (17 pp, 132 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.